Neptune Wellness Solutions Inc (NEPT)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

545 PROMENADE DU CENTROPOLIS LAVAL, QUEBEC, CANADA H7T 0A3

Neptune Technologies & Bioressources, Inc. engages in the research, development, and commercialization of novel extraction technologies and biological therapeutic agents for highly prevalent chronic conditions. It offers Neptune Krill Oil (NKO), a marine oil that provides natural blend of nutritional elements; Neptune Krill Aquatein, a marine protein concentrate that contain amino acids; and OPA3 for the functional food and biopharmaceutical markets. The company's NKO product prevents skin damages caused by chronic exposure to UV rays, reduces the physical and emotional symptoms associated with premenstrual syndrome, and provides relief from dysmenorrheal. It serves nutraceutical, pharmaceutical, nutrigenomics, and cosmetic industries. The company operates in the United States, Europe, and Asia. Neptune Technologies was founded in 1925 and is headquartered in Laval, Canada.

Data as of 2020-05-30
Market Cap282.965 Million Shares Outstanding95.062 Million Avg 30-day Volume1.401 Million
P/E Ratio Dividend Yield EPS-0.4
Price/Sales14.13 Price cash flow ratio Price free cash flow ratio-7.7
Book Value1.06 Price to Tangible Book7.85 Alpha0.02
Short Interest Ratio % Short Interest to Float R-squared0.273952
BETA2.72359 52-week High/Low6.57 / 0.96 Stddev0.22245
View SEC Filings from NEPT instead.

View recent insider trading info

Funds Holding NEPT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding NEPT BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BLUMONT CAPITAL CORP

  • 10% Owner
6,212,645 2012-11-09 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions

Elevate your investments